Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 7/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 6/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.50 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.42 |
| ▸ | AKT1 | P31749 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL6000408 | 0.80 | SLC6A4 (0.49) | SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6 | |
| SCHEMBL12204112 | 0.79 | IDO1 (0.53) | SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6 | |
| SCHEMBL12204722 | 0.78 | CYP19A1 (0.68) | CYP3A4CYP19A1AKT1CYP2C19 | |
| SCHEMBL29173259 | 0.78 | CYP19A1 (0.48) | SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6 | |
| Ammonia Solution, Strong SCHEMBL5999595 | 0.77 | SLC6A4 (0.50) | SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6 | |
| Ammonia Solution, Strong SCHEMBL5999637 | 0.77 | CYP19A1 (0.45) | SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6 | |
| SCHEMBL724559 | 0.77 | CYP3A4 (0.52) | SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6 | |
| Ammonia Solution, Strong SCHEMBL5999691 | 0.76 | PDE1B (0.42) | SLC6A4SLC6A2SLC6A3CYP19A1LMNA | |
| SCHEMBL4033388 | 0.76 | SLC6A2 (0.63) | SLC6A4SLC6A2SLC6A3CYP3A4CYP2D6 | |
| Ammonia Solution, Strong SCHEMBL5999466 | 0.74 | AKR1C3 (0.42) | SLC6A4SLC6A2SLC6A3CYP3A4CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060058357-A1 | Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke | K AND K BIOSCIENCE, INC. (US) | 2006-03-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060058357-A1 | Delta2-1,2,3-triazoline anticonvulsants and their active metabolite analogues, the aminoalkylpyridines, are excitatory amino acid antagonists and antiischemic agents, useful in the treatment of cerebral ischemia resulting from stroke | SIGMAR1, GRM1, GRIN2C | SLC6A4 1569/4885SLC6A2 1494/4885SLC6A3 789/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.